Structure Therapeutics Inc.

GPCR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$66-$62-$47-$36
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$7$8$6$6
Change in WC$10$3-$7-$1
Other Non-Cash-$3-$4-$5-$6
Operating Cash Flow-$51-$55-$52-$36
Investing Activities
PP&E Inv.-$2-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$249-$89-$116-$132
Inv. Sales/Matur.$196$138$150$166
Other Inv. Act.$5$0$0$0
Investing Cash Flow-$49$49$34$33
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$57$1$1$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$0-$0$1
Financing Cash Flow$56$1$1$1
Forex Effect$0$0$0$0
Net Chg. in Cash-$44-$5-$17-$3
Supplemental Information
Beg. Cash$147$152$170$172
End Cash$103$147$152$170
Free Cash Flow-$53-$55-$53-$36